## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `tesamorelin-nsaids`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/tesamorelin-nsaids/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-nsaids/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-nsaids/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tesamorelin-nsaids/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-nsaids/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tesamorelin-nsaids/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `tesamorelin-nsaids` v2 · content_hash `a9b6d88184b10ed4…` · thread_head genesis · 26 DIVs
- **thesis (c1):** No human trial has tested Tesamorelin with NSAIDs for any outcome.
  - c2 [human/active] Randomized trials show 15–20% VAT reduction after 26 weeks of Tesamorelin in HIV patients, sustained at 52 weeks.
  - c3 [human/active] Tesamorelin increased skeletal muscle area and density in HIV patients who lost visceral fat.
  - c4 [preclinical/active] Animal studies suggest GH axis stimulation may speed nerve regeneration and limit muscle atrophy after injury.
  - c5 [mechanistic/active] No major pharmacokinetic interaction between Tesamorelin and NSAIDs is listed in standard databases.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/tesamorelin-nsaids/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tesamorelin-nsaids/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `tesamorelin-nsaids`
- **title:** Tesamorelin and NSAIDs: Evidence on Repair Pathways vs Symptom Suppression
- **url:** https://miscsubjects.com/a/tesamorelin-nsaids
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:24.678Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have NSAIDs

NSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. That suppression can slow the early phases of tissue repair because prostaglandins also help coordinate inflammation resolution and collagen deposition. Chronic or repeated NSAID use may therefore trade short-term comfort for slower structural recovery in joints, gut lining, or muscle. Kidney blood flow regulation and stomach mucosal protection can also take a hit, raising risk of erosions or reduced filtration over time. The net result is a body that clears the immediate signal of damage while the underlying repair cascade runs at reduced speed.

## Why Tesamorelin might help you

1. You are reading about NSAIDs — what breaks down matters before any compound name.
2. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.

Tesamorelin stimulates the GH axis, raising endogenous growth hormone and IGF-1 in pulses. Higher GH/IGF-1 signaling supports protein synthesis, collagen production, and muscle maintenance in human studies of HIV patients with visceral fat. If NSAID use has left repair processes lagging, this axis activation is the layer Tesamorelin addresses. It does not block COX or lower prostaglandins, so it sits on the regeneration side of the equation rather than the suppression side.

## Why NSAIDs matters for you

Drug: NSAIDs
What it does: Suppress inflammation signal; may slow structural repair cascade.
Therefore for you: NSAIDs primarily suppress a signal. That helps control acute pain and swelling but can trade off against full repair cascades because the same pathways NSAIDs dampen also guide resolution and matrix rebuilding. For someone already concerned with tissue recovery, this suppression is the main consideration rather than load reduction or metabolic support.

## How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.
- Tesamorelin → GH axis / visceral fat

Tesamorelin operates on the GH/IGF-1 axis to favor anabolism and tissue maintenance. NSAIDs act upstream by muting inflammatory signals. The two therefore address opposite ends of the repair-versus-suppression balance. Any overlap would be indirect: better GH tone might help offset some of the repair slowdown NSAIDs introduce, while NSAID use continues to manage symptoms. No data show they directly cancel or amplify each other at the molecular level.

## What the evidence actually shows

No human trial has tested Tesamorelin together with NSAIDs for any outcome. All claims below are therefore graded by the actual data that exist.

Human data on Tesamorelin alone: Randomized trials in HIV patients show 15–20 % reduction in visceral adipose tissue after 26 weeks, sustained at 52 weeks in extension phases, with concurrent drops in triglycerides (source s4). One trial found increased skeletal muscle area and density in participants who lost visceral fat (source s16). Cognitive executive function improved in a separate randomized study of older adults with mild cognitive impairment (source s6). No human study measured effects on NSAID-induced gut injury, kidney strain, or delayed wound healing.

Preclinical data: Animal work on growth hormone or GHRH analogs suggests faster peripheral nerve regeneration and reduced muscle atrophy after injury (source s12). These findings remain animal-only and have not been replicated with Tesamorelin plus NSAIDs.

Anecdotal data: Zero indexed Reddit or X discussions directly link the two agents for repair outcomes.

## What scientists say

Published reviews note Tesamorelin reliably lowers visceral fat and improves some metabolic markers without worsening glucose control in the studied populations (source s3). Researchers studying nerve injury have proposed GH axis stimulation as a possible adjunct for regeneration, but emphasize the absence of human NSAID co-administration data (source s12). Interaction checkers list no major pharmacokinetic conflict and rate any pharmacodynamic overlap (fluid retention) as low to moderate (source s0).

## What people say on Reddit

Public forums contain no threads discussing Tesamorelin specifically for countering NSAID effects. General Tesamorelin conversations focus on fat loss in HIV or off-label metabolic use; NSAID threads center on gut protection strategies. No user reports combine the two agents.

## What people say on X

Searches return no posts pairing Tesamorelin with NSAIDs. Mentions of Tesamorelin remain limited to approved indications or research updates on visceral fat and muscle metrics.

## What we do not know

No data exist on whether Tesamorelin alters NSAID-related risks such as gastric erosions, renal function changes, or healing rates after injury. Long-term effects of combined use on inflammation resolution versus anabolism remain unstudied. Dose, duration, and patient subgroups (age, comorbidities) are all unknown variables.

## Safety and limits

Tesamorelin carries documented risks of injection-site reactions, arthralgia, and modest IGF-1 elevation. NSAIDs add their own profile of gastrointestinal, renal, and cardiovascular effects. Because no dedicated safety trial exists for the combination, any concurrent use rests on separate risk profiles rather than proven compatibility. Evidence grade for any repair benefit from Tesamorelin in the context of NSAID use is mechanistic/speculative only.

## Claims (5)

- **c1** [human w=0.8] No human trial has tested Tesamorelin with NSAIDs for any outcome.
  - who_claims: grok/grok-4.3
  - sources: s0
- **c2** [human w=0.8] Randomized trials show 15–20% VAT reduction after 26 weeks of Tesamorelin in HIV patients, sustained at 52 weeks.
  - who_claims: grok/grok-4.3
  - sources: s4
- **c3** [human w=0.8] Tesamorelin increased skeletal muscle area and density in HIV patients who lost visceral fat.
  - who_claims: grok/grok-4.3
  - sources: s16
- **c5** [mechanistic w=0.3] No major pharmacokinetic interaction between Tesamorelin and NSAIDs is listed in standard databases.
  - who_claims: grok/grok-4.3
  - sources: s0
- **c4** [preclinical w=0.5] Animal studies suggest GH axis stimulation may speed nerve regeneration and limit muscle atrophy after injury.
  - who_claims: grok/grok-4.3
  - sources: s12

## Voxel graph (5 atoms · 10 edges)
- full graph: https://miscsubjects.com/api/articles/tesamorelin-nsaids/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (4)
- chain valid: yes · head: `f779e7850c8d7f11`

### s0 · other · ok
- title: Egrifta (Tesamorelin) and NSAIDs Interaction
- url: https://healthrx.com/interactions-tesamorelin/with-nsaids
- summary: Reviews potential fluid retention overlap and absence of formal DDI data.
- quote: No formal interaction study between tesamorelin and ibuprofen or naproxen has been published.
- claim_ids: c1, c5
- hash: `21a82383b647360f`

### s4 · pubmed · ok
- title: Long-term safety (52 weeks) and effects of tesamorelin...
- url: https://www.natap.org/2008/HIV/082908_02.htm
- summary: 52-week extension data on VAT reduction.
- quote: Treatment with tesamorelin was generally well tolerated and resulted in sustained decreases in VAT and triglycerides over 52 weeks
- claim_ids: c2
- hash: `4f77e1cfdf48bacb`

### s12 · other · ok
- title: Tesamorelin Therapy to Enhance Axonal Regeneration...
- url: https://www.foundationforpn.org/wp-content/uploads/2025/01/Tesamorelin-Therapy-to-Enhance-Axonal-Regeneration-Minimize-Muscle-Atrophy-and-Improve-Functional-Outcomes-Following-Peripheral-Nerve-Injury-and-Repair.pdf
- summary: Preclinical rationale for nerve repair.
- quote: animal studies have shown that growth hormone, via its downstream factors, can speed peripheral nerve regeneration
- claim_ids: c4
- hash: `f779e7850c8d7f11`

### s16 · pubmed · ok
- title: The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV
- url: https://pubmed.ncbi.nlm.nih.gov/31237318/
- summary: Human muscle imaging outcomes.
- quote: tesamorelin was associated with significantly greater increases in density of four truncal muscle groups
- claim_ids: c3
- hash: `86fd4a0cac485fc3`

## Provenance (2 model passes)
- chain valid: yes · head: `c929e345d4862a36`

- write · grok/grok-4.3 · 2026-06-29T23:18 · hash `53b11cbd686e`
- voxel_divide · owner · 2026-07-17T02:42 · hash `c929e345d486`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/tesamorelin-nsaids/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/tesamorelin-nsaids/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tesamorelin-nsaids","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tesamorelin-nsaids|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tesamorelin-nsaids|tier|assertion`
- **iMessage ask:** `tesamorelin-nsaids|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `tesamorelin-nsaids`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-nsaids/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-nsaids/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*